TSENTR KLINICHESKOY ONKOLOGII I GEMATOLOGII, OOO, Crimea

Economic indicators

Net profit (RAS) of TSENTR KLINICHESKOY ONKOLOGII I GEMATOLOGII, OOO dropped in 2023 by 7.55% to 19.27 million RUB from 20.84 million RUB over the same period in 2022, the company informed.

Revenue decreased in the accounting period 6.37 times to 106.01 million RUB from 675.11 million RUB in 2022; cost of goods sold decreased 7.62 times to 85.82 million RUB from 653.52 million RUB; sales profit fell by 6.62% to 19.80 million RUB from 21.20 million RUB.

Net profit (RAS) of TSENTR KLINICHESKOY ONKOLOGII I GEMATOLOGII, OOO grew over 2022 4.99 times to 20.84 million RUB from 4.18 million RUB over 2021, the company informed.

Revenue decreased in the accounting period by 13.11% to 675.11 million RUB from 777.00 million RUB in 2021; cost of goods sold decreased by 14.77% to 653.52 million RUB from 766.78 million RUB; sales profit went up 3.63 times to 21.20 million RUB from 5.84 million RUB.

Net profit (RAS) of TSENTR KLINICHESKOY ONKOLOGII I GEMATOLOGII, OOO made up 4.18 million RUB over 2021 compared to net loss of 13.32 million RUB over 2020, the company informed.

Revenue increased in the accounting period by 19.10% to 777.00 million RUB from 652.40 million RUB over 2020; cost of goods sold grew by 25.40% to 766.78 million RUB from 611.48 million RUB; sales profit fell 5.86 times to 5.84 million RUB from 34.23 million RUB.

Net loss (RAS) of TSENTR KLINICHESKOY ONKOLOGII I GEMATOLOGII, OOO increased by 26.37% to 13.32 million RUB from 10.54 million RUB over 2019, the company informed.

Revenue increased in the accounting period 2.36 times to 652.40 million RUB from 276.44 million RUB over 2019; cost of goods sold grew 2.30 times to 611.48 million RUB from 265.33 million RUB; sales profit made up 34.23 million RUB compared to sales loss of 1.75 million RUB.

Net loss (RA) of TSENTR KLINICHESKOY ONKOLOGII I GEMATOLOGII, OOO made up 10.54 million RUB over 2019 compared to net profit of 5.67 million RUB over 2018, the company informed.

Revenue increased in the accounting period 5.57 times to 276.44 million RUB from 49.67 million RUB over 2018; cost of goods sold grew 8.31 times to 265.33 million RUB from 31.93 million RUB; sales loss made up 1.75 million RUB compared to sales profit of 5.69 million RUB.

Net profit (RAS) of TSENTR KLINICHESKOY ONKOLOGII I GEMATOLOGII, OOO over 2018 was the same as in 2017 reaching 5.67 million RUB, the company informed.

Revenue decreased in the accounting period by 4.06% to 49.67 million RUB from 51.78 million RUB in 2017; cost of goods sold decreased by 10.32% to 31.93 million RUB from 35.61 million RUB; sales profit matched the previous year’s result amounting to 5.69 million RUB.

Net profit (RAS) of TSENTR KLINICHESKOY DIAGNOSTIKI, OOO made up 5.65 million RUB over 2017 compared to net loss of 6.85 million RUB over 2016, the company informed.

Revenue increased in the accounting period 1.91 times to 51.78 million RUB from 27.11 million RUB over 2016; cost of goods sold grew 2.07 times to 35.61 million RUB from 17.19 million RUB; sales profit went up 9.79 times to 5.69 million RUB from 581.00 thousand RUB.

Companies in the region

• GARANT-IV
• KRYMEKSPRESSPRODUKT
• KATOK
• KLUB ZHEMCHUZHINA
• KAREON